FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1996595714> ?p ?o ?g. }

• W1996595714 endingPage "15057" @default.
• W1996595714 startingPage "15050" @default.
• W1996595714 abstract "Both TGF-β and myocardin (MYOCD) are important for smooth muscle cell (SMC) differentiation, but their precise role in regulating the initiation of SMC development is less clear. In TGF-β-induced SMC differentiation of pluripotent C3H10T1/2 progenitors, we found that TGF-β did not significantly induce Myocd mRNA expression until 18 h of stimulation. On the other hand, early SMC markers such as SM α-actin, SM22α, and SM calponin were detectable beginning 2 or 4 h after TGF-β treatment. These results suggest that Myocd expression is blocked during the initiation of TGF-β-induced SMC differentiation. Consistent with its endogenous expression, Myocd promoter activity was not elevated until 18 h following TGF-β stimulation. Surprisingly, Smad signaling was inhibitory to Myocd expression because blockade of Smad signaling enhanced Myocd promoter activity. Overexpression of Smad3, but not Smad2, inhibited Myocd promoter activity. Conversely, shRNA knockdown of Smad3 allowed TGF-β to activate the Myocd promoter in the initial phase of induction. Myocd was activated by PI3 kinase signaling and its downstream target Nkx2.5. Interestingly, Smad3 did not affect PI3 kinase activity. However, Smad3 physically interacted with Nkx2.5. This interaction blocked Nkx2.5 binding to the Myocd promoter in the early stage of TGF-β induction, leading to inhibition of Myocd mRNA expression. Moreover, Smad3 inhibited Nkx2.5-activated Myocd promoter activity in a dose-dependent manner. Taken together, our results reveal a novel mechanism for Smad3-mediated inhibition of Myocd in the initiation phase of SMC differentiation. Both TGF-β and myocardin (MYOCD) are important for smooth muscle cell (SMC) differentiation, but their precise role in regulating the initiation of SMC development is less clear. In TGF-β-induced SMC differentiation of pluripotent C3H10T1/2 progenitors, we found that TGF-β did not significantly induce Myocd mRNA expression until 18 h of stimulation. On the other hand, early SMC markers such as SM α-actin, SM22α, and SM calponin were detectable beginning 2 or 4 h after TGF-β treatment. These results suggest that Myocd expression is blocked during the initiation of TGF-β-induced SMC differentiation. Consistent with its endogenous expression, Myocd promoter activity was not elevated until 18 h following TGF-β stimulation. Surprisingly, Smad signaling was inhibitory to Myocd expression because blockade of Smad signaling enhanced Myocd promoter activity. Overexpression of Smad3, but not Smad2, inhibited Myocd promoter activity. Conversely, shRNA knockdown of Smad3 allowed TGF-β to activate the Myocd promoter in the initial phase of induction. Myocd was activated by PI3 kinase signaling and its downstream target Nkx2.5. Interestingly, Smad3 did not affect PI3 kinase activity. However, Smad3 physically interacted with Nkx2.5. This interaction blocked Nkx2.5 binding to the Myocd promoter in the early stage of TGF-β induction, leading to inhibition of Myocd mRNA expression. Moreover, Smad3 inhibited Nkx2.5-activated Myocd promoter activity in a dose-dependent manner. Taken together, our results reveal a novel mechanism for Smad3-mediated inhibition of Myocd in the initiation phase of SMC differentiation." @default.
• W1996595714 created "2016-06-24" @default.
• W1996595714 creator A5003996472 @default.
• W1996595714 creator A5053845091 @default.
• W1996595714 creator A5056467370 @default.
• W1996595714 creator A5080731495 @default.
• W1996595714 creator A5083663683 @default.
• W1996595714 date "2011-04-01" @default.
• W1996595714 modified "2023-10-16" @default.
• W1996595714 title "Smad3-mediated Myocardin Silencing" @default.
• W1996595714 cites W1532393868 @default.
• W1996595714 cites W1533133582 @default.
• W1996595714 cites W1535175417 @default.
• W1996595714 cites W1576609386 @default.
• W1996595714 cites W1582207864 @default.
• W1996595714 cites W1943962033 @default.
• W1996595714 cites W1966222469 @default.
• W1996595714 cites W1969361725 @default.
• W1996595714 cites W1975522586 @default.
• W1996595714 cites W1976805189 @default.
• W1996595714 cites W1979935374 @default.
• W1996595714 cites W1980394179 @default.
• W1996595714 cites W1983043887 @default.
• W1996595714 cites W1996630410 @default.
• W1996595714 cites W2005152193 @default.
• W1996595714 cites W2014840129 @default.
• W1996595714 cites W2016270174 @default.
• W1996595714 cites W2021263701 @default.
• W1996595714 cites W2035653659 @default.
• W1996595714 cites W2052703031 @default.
• W1996595714 cites W2057307695 @default.
• W1996595714 cites W2064323791 @default.
• W1996595714 cites W2089171495 @default.
• W1996595714 cites W2096628719 @default.
• W1996595714 cites W2102385086 @default.
• W1996595714 cites W2103600292 @default.
• W1996595714 cites W2104002497 @default.
• W1996595714 cites W2108270018 @default.
• W1996595714 cites W2110743056 @default.
• W1996595714 cites W2113175417 @default.
• W1996595714 cites W2118199431 @default.
• W1996595714 cites W2121822802 @default.
• W1996595714 cites W2123525273 @default.
• W1996595714 cites W2137281565 @default.
• W1996595714 cites W2146550461 @default.
• W1996595714 cites W2147865760 @default.
• W1996595714 cites W2148664347 @default.
• W1996595714 cites W2150581509 @default.
• W1996595714 cites W2156606731 @default.
• W1996595714 cites W2162238950 @default.
• W1996595714 cites W2163504684 @default.
• W1996595714 cites W2164218605 @default.
• W1996595714 cites W2167048243 @default.
• W1996595714 cites W2168192071 @default.
• W1996595714 doi "https://doi.org/10.1074/jbc.m110.202747" @default.
• W1996595714 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3083168" @default.
• W1996595714 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21402709" @default.
• W1996595714 hasPublicationYear "2011" @default.
• W1996595714 type Work @default.
• W1996595714 sameAs 1996595714 @default.
• W1996595714 citedByCount "46" @default.
• W1996595714 countsByYear W19965957142012 @default.
• W1996595714 countsByYear W19965957142013 @default.
• W1996595714 countsByYear W19965957142014 @default.
• W1996595714 countsByYear W19965957142015 @default.
• W1996595714 countsByYear W19965957142016 @default.
• W1996595714 countsByYear W19965957142017 @default.
• W1996595714 countsByYear W19965957142018 @default.
• W1996595714 countsByYear W19965957142019 @default.
• W1996595714 countsByYear W19965957142020 @default.
• W1996595714 countsByYear W19965957142021 @default.
• W1996595714 countsByYear W19965957142022 @default.
• W1996595714 crossrefType "journal-article" @default.
• W1996595714 hasAuthorship W1996595714A5003996472 @default.
• W1996595714 hasAuthorship W1996595714A5053845091 @default.
• W1996595714 hasAuthorship W1996595714A5056467370 @default.
• W1996595714 hasAuthorship W1996595714A5080731495 @default.
• W1996595714 hasAuthorship W1996595714A5083663683 @default.
• W1996595714 hasBestOaLocation W19965957141 @default.
• W1996595714 hasConcept C104317684 @default.
• W1996595714 hasConcept C119056186 @default.
• W1996595714 hasConcept C125705527 @default.
• W1996595714 hasConcept C126322002 @default.
• W1996595714 hasConcept C134018914 @default.
• W1996595714 hasConcept C150194340 @default.
• W1996595714 hasConcept C173396325 @default.
• W1996595714 hasConcept C185592680 @default.
• W1996595714 hasConcept C2780286377 @default.
• W1996595714 hasConcept C2781080636 @default.
• W1996595714 hasConcept C2781122658 @default.
• W1996595714 hasConcept C55493867 @default.
• W1996595714 hasConcept C62478195 @default.
• W1996595714 hasConcept C69053785 @default.
• W1996595714 hasConcept C71924100 @default.
• W1996595714 hasConcept C86803240 @default.
• W1996595714 hasConcept C95444343 @default.
• W1996595714 hasConceptScore W1996595714C104317684 @default.
• W1996595714 hasConceptScore W1996595714C119056186 @default.

• next